Monoclonal Antibodies Recognizing Normal and Neoplastic Human Adrenal Cortex

Area of Science:

• Endocrinology
• Immunology
• Oncology

Background:

• Accurate histological recognition of human adrenal lesions is crucial for diagnosis and treatment.
• Current diagnostic tools may benefit from novel biomarkers for improved specificity.

Purpose of the Study:

• To generate and characterize novel monoclonal antibodies (mAbs) for potential use in diagnosing human adrenal gland tumors.
• To assess the reactivity and specificity of these mAbs against normal adrenal tissue, adrenal tumors, and other human tissues.

Main Methods:

• Immunization of mice with cells from normal human adrenal glands and adrenocortical adenomas.
• Immunohistochemistry on cryosections and immunofluorescence on dispersed cells for differential labeling.
• Immunoprecipitation to identify recognized molecular structures (51-88 kDa).
• Testing antibody reactivity against normal tissues, various adrenal tumors (adenomas, carcinomas), and other pathologies (renal cell carcinoma, pheochromocytoma).

Main Results:

• Four mAbs (Na2, Na7, Ac5) were generated, with Ac5 uniquely labeling cell surfaces.
• Antibodies showed restricted reactivity in normal human tissues, sparing the adrenal medulla.
• All generated mAbs recognized the majority of adrenocortical adenomas and carcinomas, with Na7 showing intense staining.
• Na2 exhibited highly restricted reactivity, and none of the antibodies stained renal cell carcinomas or pheochromocytomas.

Conclusions:

• The developed monoclonal antibodies demonstrate specific reactivity patterns against human adrenal lesions.
• These antibodies hold potential for enhancing the histological recognition and characterization of adrenal adenomas and carcinomas.
• Further research may establish these mAbs as valuable diagnostic tools in endocrinology and oncology.